$5.5 million study to probe the impact of marijuana legalization on use, behavior, mental health.
This collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guidelines.
The authors of the research also commented on the need for further research stressing that there is a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of any treatment.
38% of resident physicians think medical marijuana is a prescribed substance, while 78% do not know what category medical cannabis falls within the Controlled Substance Act.
Professor Raphael Mechoulam, a cannabis research pioneer, has just received funding to identify a possible inhibitory effect of a derivative of cannabidiol on allergic airway inflammation.
The Netherlands has long been known for its relatively liberal approach to cannabis but testing is far from commonplace here.
New findings suggest that persistent THC exposure may alter the inhibitory function of VTA GABA cells, increasing dopamine levels and the rewarding features of marijuana.
By determining the optimal amount of fertilizer and developing soilless growing substrates researchers have produced high-yielding plants rich in CBD and THC.
DNA sequencing has allowed scientists to compile robust genetic profiles of organisms large and small, but Cannabis has remained a high-profile exception, until now.